Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1983 May;71(5):1104–1113. doi: 10.1172/JCI110860

Synthesis of antibodies to hepatitis B virus by cultured lymphocytes from chronic hepatitis B surface antigen carriers.

G M Dusheiko, J H Hoofnagle, W G Cooksley, S P James, E A Jones
PMCID: PMC436971  PMID: 6602149

Abstract

It has been postulated that host immune defects are responsible for the development and persistence of the hepatitis B surface antigen (HBsAg) carrier state. The nature of these defects is unknown, but the absence of a readily detectable antibody response to HBsAg (anti-HBs) may be important. The synthesis of both anti-HBs and antibody to hepatitis B core antigen (anti-HBc) in cultures containing peripheral blood mononuclear cells from chronic HBsAg carriers and from control (antibody-positive) patients was measured in the presence of pokeweed mitogen. Similar amounts of polyclonal IgG and IgM were synthesized by cultures containing lymphocytes from chronic carriers and controls. Anti-HBc was detectable in lymphocyte supernatants from 2 of 20 controls and from 21 of 29 carriers. The presence of anti-HBc synthesis in vitro correlated with high serum titers of anti-HBc. In contrast, anti-HBs was detected in lymphocyte supernatants from 6 of 20 controls (predominantly in those who had high serum titers of anti-HBs) but in none of the supernatants from 29 HBsAg carriers. In order to identify the mechanisms for the lack of detectable anti-HBs synthesis by chronic HBsAg carrier lymphocytes, co-culture experiments were performed using T and B lymphocyte fractions that had been purified by affinity chromatography. B lymphocytes from carriers co-cultured with allogeneic irradiated ("helper") T lymphocytes from controls synthesized normal amounts of IgG, IgM, and anti-HBc but still did not synthesize detectable amounts of anti-HBs. In the converse experiments, B lymphocytes from controls were co-cultured with irradiated T lymphocytes from carriers. The T lymphocytes from 16 of 24 carriers augmented anti-HBs production by control B cells normally, the remaining eight did not. Finally, mixtures of control B cells and control irradiated T lymphocytes were co-cultured with T lymphocytes from chronic HBsAg carriers. 5 of 12 carriers demonstrated active suppression of anti-HBs production, and in three this suppression was specific, as IgG and IgM production remained normal. We conclude that chronic HBsAg carriers have a specific B lymphocyte defect in anti-HBs production. In addition, defects in the function of regulatory T lymphocytes may contribute to the absence of anti-HBs synthesis in some HBsAg carriers.

Full text

PDF
1104

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aldershvile J., Dietrichson O., Hardt F., Nielsen J. O., Skinhöj P. Humoral and cell-mediated immunity to hepatitis B virus antigens in acute and chronic liver disease. Scand J Gastroenterol. 1977;12(8):917–922. doi: 10.3109/00365527709181350. [DOI] [PubMed] [Google Scholar]
  2. Almeida J. D., Waterson A. P. Immune complexes in hepatitis. Lancet. 1969 Nov 8;2(7628):983–986. doi: 10.1016/s0140-6736(69)90540-6. [DOI] [PubMed] [Google Scholar]
  3. Blumberg B. S., Sutnick A. I., London W. T. Australia antigen as a hepatitis virus. Variation in host response. Am J Med. 1970 Jan;48(1):1–8. doi: 10.1016/0002-9343(70)90093-8. [DOI] [PubMed] [Google Scholar]
  4. Bolin T. D., Davis A. E., Liddelow A. G. Liver disease and cell-mediated immunity in hepatitis-associated antigen (HAA) carriers. Gut. 1973 May;14(5):365–368. doi: 10.1136/gut.14.5.365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bøyum A. Isolation of lymphocytes, granulocytes and macrophages. Scand J Immunol. 1976 Jun;Suppl 5:9–15. [PubMed] [Google Scholar]
  6. Chess L., MacDermott R. P., Schlossman S. F. Immunologic functions of isolated human lymphocyte subpopulations. I. Quantitative isolation of human T and B cells and response to mitogens. J Immunol. 1974 Oct;113(4):1113–1121. [PubMed] [Google Scholar]
  7. Desaules M., Frei P. C., Libanska J., Wuilleret B. Lack of leukocyte migration inhibition by hepatitis B antigen and normal nonspecific immunoreactivity in asymptomatic carriers. J Infect Dis. 1976 Nov;134(5):505–509. doi: 10.1093/infdis/134.5.505. [DOI] [PubMed] [Google Scholar]
  8. Diener E., Feldmann M. Mechanisms at the cellular level during induction of high zone tolerance in vitro. Cell Immunol. 1972 Sep;5(1):130–136. doi: 10.1016/0008-8749(72)90090-1. [DOI] [PubMed] [Google Scholar]
  9. Dudley F. J., Fox R. A., Sherlock S. Cellular immunity and hepatitis-associated, Australia antigen liver disease. Lancet. 1972 Apr 1;1(7753):723–726. doi: 10.1016/s0140-6736(72)90234-6. [DOI] [PubMed] [Google Scholar]
  10. Feighery C., Greally J. F., Weir D. G. Mitogen responsiveness in viral hepatitis and chronic active hepatitis: the role of reversible suppressive influences. Gut. 1980 Sep;21(9):738–744. doi: 10.1136/gut.21.9.738. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. James S. P., Elson C. O., Jones E. A., Strober W. Abnormal regulation of immunoglobulin synthesis in vitro in primary biliary cirrhosis. Gastroenterology. 1980 Aug;79(2):242–254. [PubMed] [Google Scholar]
  12. Kaplan P. M., Greenman R. L., Gerin J. L., Purcell R. H., Robinson W. S. DNA polymerase associated with human hepatitis B antigen. J Virol. 1973 Nov;12(5):995–1005. doi: 10.1128/jvi.12.5.995-1005.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Katz P., Fauci A. S. Inhibition of polyclonal B-cell activation by suppressor monocytes in patients with sarcoidosis. Clin Exp Immunol. 1978 Jun;32(3):554–562. [PMC free article] [PubMed] [Google Scholar]
  14. Lander J. J., Alter H. J., Purcell R. H. Frequency of antibody to hepatitis-associated antigen as measured by a new radioimmunoassay technique. J Immunol. 1971 May;106(5):1166–1171. [PubMed] [Google Scholar]
  15. Laughter A. H., Lidsky M. D., Twomey J. J. Suppression of immunoglobulin synthesis by monocytes in health and in patients with systemic lupus erythematosus. Clin Immunol Immunopathol. 1979 Dec;14(4):435–440. doi: 10.1016/0090-1229(79)90095-3. [DOI] [PubMed] [Google Scholar]
  16. Levo Y., Shouval D., Tur-Kaspa R., Wollner S., Penchas S., Zlotnick A., Eliakim M. Immunological evaluation of asymptomatic carriers of hepatitis B virus. Clin Exp Immunol. 1981 Apr;44(1):63–67. [PMC free article] [PubMed] [Google Scholar]
  17. Madaliński K., Sztachelska-Budkowska A., Brzosko W. J. DEAE-cellulose chromatography: a method for dissociation of soluble immune complexes of hepatitis B antigen. J Infect Dis. 1974 Apr;129(4):371–375. doi: 10.1093/infdis/129.4.371. [DOI] [PubMed] [Google Scholar]
  18. Mudawwar F. B., Yunis E. J., Geha R. S. Antigen-specific helper factor in man. J Exp Med. 1978 Oct 1;148(4):1032–1043. doi: 10.1084/jem.148.4.1032. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Mutchnick M. G., Lederman H. M., Missirian A., Johnson A. G. In vitro synthesis of IgG by peripheral blood lymphocytes in chronic liver disease. Clin Exp Immunol. 1981 Feb;43(2):370–375. [PMC free article] [PubMed] [Google Scholar]
  20. Nielsen J. O., Reinicke V., Dietrichson O., Andersen V., Thomsen M., Andersen E. Immunological studies of Australia antigen carriers with and without liver diseases. Clin Exp Immunol. 1973 Sep;15(1):9–16. [PMC free article] [PubMed] [Google Scholar]
  21. Purcell R. H., Gerin J. L. Hepatitis B vaccines. On the threshold. Am J Clin Pathol. 1978 Jul;70(1 Suppl):159–169. [PubMed] [Google Scholar]
  22. Rümke H. C., Terpstra F. G., Huis B., Out T. A., Zeijlemaker W. P. Immunoglobulin production in human mixed lymphocyte cultures: implications for co-cultures of cells from patients and healthy donors. J Immunol. 1982 Feb;128(2):696–701. [PubMed] [Google Scholar]
  23. Serjeantson S., Woodfield D. G. Immune response of leprosy patients to hepatitis B virus. Am J Epidemiol. 1978 Apr;107(4):321–327. doi: 10.1093/oxfordjournals.aje.a112547. [DOI] [PubMed] [Google Scholar]
  24. Shulman N. R., Barker L. F. Virus-like antigen, antibody, and antigen-antibody complexes in hepatitis measured by complement fixation. Science. 1969 Jul 18;165(3890):304–306. doi: 10.1126/science.165.3890.304. [DOI] [PubMed] [Google Scholar]
  25. Siegal F. P., Siegal M. Enhancement by irradiated T cells of human plasma cell production: dissection of helper and suppressor functions in vitro. J Immunol. 1977 Feb;118(2):642–647. [PubMed] [Google Scholar]
  26. Stevens R. H. Immunoglobulin-bearing cells are a target for the antigen-induced inhibition of pokeweed mitogen-stimulated antibody production. J Immunol. 1981 Sep;127(3):968–972. [PubMed] [Google Scholar]
  27. Stevens R. H., Saxon A. Immunoregulation in humans: control of antitetanus toxoid antibody production after booster immunization. J Clin Invest. 1978 Dec;62(6):1154–1160. doi: 10.1172/JCI109234. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Sutnick A. I., Bugbee S. J., London W. T., Loeb L. A., Peyretti F., Litwin S., Blumberg B. S. Lymphocyte function in normal people with persistent Australia antigen. J Lab Clin Med. 1973 Jul;82(1):79–85. [PubMed] [Google Scholar]
  29. Swain S. L., Trefts P. E., Tse H. Y., Dutton R. W. The significance of T-B collaboration across haplotype barriers. Cold Spring Harb Symp Quant Biol. 1977;41(Pt 2):597–609. doi: 10.1101/sqb.1977.041.01.069. [DOI] [PubMed] [Google Scholar]
  30. Tabor E., Gerety R. J., Smallwood L. A., Barker L. F. Coincident hepatitis B surface antigen and antibodies of different subtypes in human serum. J Immunol. 1977 Jan;118(1):369–370. [PubMed] [Google Scholar]
  31. Tong M. J., Wallace A. M., Peters R. L., Reynolds T. B. Lymphocyte stimulation in hepatitis B infections. N Engl J Med. 1975 Aug 14;293(7):318–322. doi: 10.1056/NEJM197508142930702. [DOI] [PubMed] [Google Scholar]
  32. Volkman D. J., Lane H. C., Fauci A. S. Antigen-induced in vitro antibody production in humans: a model for B cell activation and immunoregulation. Proc Natl Acad Sci U S A. 1981 Apr;78(4):2528–2531. doi: 10.1073/pnas.78.4.2528. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Wands J. R., Mann E., Alpert E., Isselbacher K. J. The pathogenesis of arthritis associated with acute hepatitis-B surface antigen-positive hepatitis. Complement activation and characterization of circulating immune complexes. J Clin Invest. 1975 May;55(5):930–936. doi: 10.1172/JCI108022. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES